Company / Revenue
MADRIGAL PHARMACEUTICALS, INC. Revenue History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$958.4M
FY2025
5-year range
$0 / $958.4M
FY2021-FY2025
Trend
+432.1%
vs FY2024
Sector context
#42 of 155
Health Care
What the data says
At $958M, MADRIGAL PHARMACEUTICALS, INC.'s revenue ranks #42 of 155 in the Health Care sector. Improved from $0 to $958M over the past 2 years.
Based on SEC 10-K filings.
$958M in FY2025.
Improved from $0 to $958M over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#42 of 155 in Health CareTop 27% of 155This company $958.4M Sector average $4.5B
▼
-78.6% below sector average
Key checks
Key Insights
- In FY2025, revenue increased 432.1% year-over-year.
- Ranks #42 out of 155 companies in the Health Care sector.
- Lowest revenue in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $958.4M | +432.1% |
| FY2024 | $180.1M | - |
| FY2023 | $0 | - |
| FY2022 | $0 | - |
| FY2021 | $0 | - |
| FY2020 | $0 | - |
| FY2019 | $0 | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026